FDA Inspection 1283264 — Nippon Shikizai, Inc.

Nippon Shikizai, Inc. — FEI 3012051074

The FDA completed an inspection of Nippon Shikizai, Inc. on Sep 12, 2025 in Tsukuba. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 12, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tsukuba (Japan)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
183321 CFR 211.84(d)(1)Identity Testing of Each Component
192021 CFR 211.166(a)(3)Valid stability test methods
197621 CFR 211.182Specific information required in individual logs
202721 CFR 211.192Investigations of discrepancies, failures
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.